Source: International Congress 2019 – More and more COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Etminan (Vancouver, Canada), A. Samii (Vancouver, Canada), M. Sadatsafavi (Vancouver, Canada), H. Tavakoli (Vancouver, Canada), W. Chen (Vancouver, Canada). Effects of Regular Use of ß2-Adrenergic Receptor Agonists on the Risk of Parkinson’s Disease in Patients with COPD. 4435

Member's Comments

No comment yet.

Related content which might interest you: Does a Tailored Intervention to Promote Adherence in Patients with Chronic Lung Disease Affect Exacerbations? Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 Relation of Respiratory Function and Functional Capacity, Body Composition in Individuals with Alzheimer’s Disease Source: Virtual Congress 2020 – A knowledge update on respiratory muscle function, assessment and training Year: 2020 High Intensity Resistance Training Improves Respiratory, Peripheral, Quality of Life and Emotional Response in Elderly with Parkinson Disease Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases Year: 2017 Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019 Study Of Risk Factors For Arrhythmias Among Chronic Obstructive Pulmonary Disease Patients Having Ischaemic Heart Disease. Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 Study to Evaluate Satisfaction with the Inhalation Device Used by Patients with Asthma or Chronic Obstructive Pulmonary Disease and the Association with Adherence and Disease Control Source: Virtual Congress 2020 – Novel insights into nursing interventions for managing patients with asthma and COPD Year: 2020 Respiratory and Motor Phenotypes and Correlations with Diaphragm Function in Patients with Late-Onset Pompe Disease (LOPD) Source: International Congress 2018 – The value of lung function testing in various pathophysiological conditions Year: 2018 Smart Watch-based Coaching with Tiotropium and Olodaterol Ameliorates Physical Activity in Chronic Obstructive Pulmonary Disease Patients Source: International Congress 2017 – Bronchodilators and bronchoprotectors Year: 2017 Patterns of Oxygen Pulse Response to Incremental Exercise in Patients with Chronic Obstructive Pulmonary Disease – An Observational Study Source: International Congress 2017 – Exercise testing in cardiorespiratory diseases Year: 2017 Long-Acting Beta Agonist Asthma Pharmacogenetic Loci Identified in Two Multi-Racial Asthma Clinical Trials Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021 Evaluation of Co-morbidities among Different Chronic Obstructive Pulmonary Disease Phenotypes Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 A First-in-Class PRS Inhibitor, DWN12088, as a Novel Therapeutic Agent for Systemic Sclerosis and Associated Interstitial Lung Disease Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases Year: 2021 The Frequency of Small Airway Dysfunction and Its Relationship with Disease Control in Chronic Airway Diseases Source: Virtual Congress 2021 – Lung function testing in the management of obstructive diseases Year: 2021 The Impact of Multimorbidity on Hospitalizations in Patients with Chronic Obstructive Pulmonary Disease (COPD): a Population-Based Study Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Risk Factor for Chronic Obstructive Pulmonary Disease in Never-Smoker Patients with Non-Cystic Fibrosis Bronchiectasis Source: International Congress 2019 – Bronchiectasis Year: 2019 Bone Metabolism in OSAS Patients and the Effect of One Year Treatment with Non-Invasive Ventilation Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence Year: 2020 Overweight Motor Neurone Disease Patients with Bulbar Dysfunction: High Risk Gastrostomy Tube Insertion Source: Virtual Congress 2020 – Non-invasive ventilation and nasal high flow: technical aspects and predictive scores Year: 2020 Update on CADSET (Chronic Airway Disease Early Stratification) Clinical Research Collaboration Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases Year: 2020 Diffuse Pulmonary Non-Amyloid Light-Chain Deposition Disease: Phenotypes and Outcome Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases Year: 2021 Dupilumab Effect on Lung Function in Patients With Uncontrolled, Moderate-to-Severe Asthma With an Allergic Phenotype Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019